These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10665640)

  • 1. Tardive dyskinesia associated with olanzapine monotherapy.
    Ananth J; Kenan J
    J Clin Psychiatry; 1999 Dec; 60(12):870. PubMed ID: 10665640
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dystonia associated with olanzapine therapy.
    Gunal DI; Onultan O; Afsar N; Aktan S
    Neurol Sci; 2001 Aug; 22(4):331-2. PubMed ID: 11808858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-induced tardive dystonia.
    Dunayevich E; Strakowski SM
    Am J Psychiatry; 1999 Oct; 156(10):1662. PubMed ID: 10518183
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked reduction of tardive dyskinesia with olanzapine.
    Littrell KH; Johnson CG; Littrell S; Peabody CD
    Arch Gen Psychiatry; 1998 Mar; 55(3):279-80. PubMed ID: 9510225
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute dystonia with olanzapine.
    Landry P; Cournoyer J
    J Clin Psychiatry; 1998 Jul; 59(7):384. PubMed ID: 9714272
    [No Abstract]   [Full Text] [Related]  

  • 6. Ondansetron for tardive dyskinesia.
    Zullino DF; Eap CB; Voirol P
    Am J Psychiatry; 2001 Apr; 158(4):657-8. PubMed ID: 11282718
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia associated with olanzapine.
    Herrán A; Vázquez-Barquero JL
    Ann Intern Med; 1999 Jul; 131(1):72. PubMed ID: 10391826
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine for the treatment of tardive dyskinesia.
    Almeida OP
    J Clin Psychiatry; 1998 Jul; 59(7):380-1. PubMed ID: 9714267
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases.
    Agarwal V; Kumar P
    J Clin Psychiatry; 2001 Apr; 62(4):298-9. PubMed ID: 11379849
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

  • 11. Olanzepine-induced tardive dyskinesia.
    Bella VL; Piccoli F
    Br J Psychiatry; 2003 Jan; 182():81-2. PubMed ID: 12509329
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine.
    Lykouras L; Agelopoulos E; Tzavellas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):815-7. PubMed ID: 12188112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of tardive dyskinesia in a bipolar patient with olanzapine.
    Esel E; Turan MT; Sofuoglu S; Gönül AS
    Eur Psychiatry; 2000 Nov; 15(7):438-9. PubMed ID: 11112937
    [No Abstract]   [Full Text] [Related]  

  • 15. Manic symptoms induced by olanzapine.
    Lykouras L; Gournellis R; Angelopoulos E
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):97-8. PubMed ID: 11313153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol treatment of olanzapine-induced akathisia.
    Kurzthaler I; Hummer M; Kohl C; Miller C; Fleischhacker WW
    Am J Psychiatry; 1997 Sep; 154(9):1316. PubMed ID: 9286196
    [No Abstract]   [Full Text] [Related]  

  • 17. Case report: possible neuroleptic malignant syndrome associated with olanzapine.
    Moltz DA; Coeytaux RR
    J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe hypertriglyceridemia associated with olanzapine.
    Stoner SC; Dubisar BM; Khan R; Farrar CD
    J Clin Psychiatry; 2002 Oct; 63(10):948-9. PubMed ID: 12416606
    [No Abstract]   [Full Text] [Related]  

  • 19. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine-induced neutropenia.
    Gajwani P; Tesar GE
    Psychosomatics; 2000; 41(2):150-1. PubMed ID: 10749954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.